Hematology TimesFDA approves drug for hairy cell leukemiaSeptember 14, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesEC approves product for von Willebrand diseaseSeptember 14, 2018ThrombosisPharmacyBleeding Disorders
Hematology TimesHemophilia B drug available in larger vialSeptember 11, 2018ThrombosisPharmacyBleeding Disorders
Hematology TimesFirst CAR T-cell therapy approved in CanadaSeptember 7, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsPharmacyALLAggressive LymphomasFollicular Lymphoma
Hematology TimesCAR T-cell therapy will soon be available in England, NHS saysSeptember 6, 2018Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALLB Cell Lymphoma
Hematology TimesCaplacizumab approved to treat aTTPSeptember 4, 2018ThrombosisPharmacyBleeding Disorders
Hematology TimesDaratumumab approved for new indication in MMSeptember 1, 2018Multiple MyelomaPharmacy
Hematology TimesFactor VIII product approved for hemophilia AAugust 31, 2018ThrombosisPharmacyBleeding Disorders
Hematology TimesEC approves blinatumomab for kidsAugust 30, 2018Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL
Hematology TimesEC approves product for high-risk AMLAugust 28, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesEC approves CAR T-cell therapy for ALL, DLBCLAugust 27, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyALLNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesCHMP recommends expanded approval for daratumumabJuly 31, 2018Multiple MyelomaPharmacy
